STAT+: Five biotech updates to read after ESMO this weekend
· statnews.com · popularity 32/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at statnews.com →
Summary
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 9.